Farringdon Capital Ltd. Takes Position in Henry Schein, Inc. (NASDAQ:HSIC)

Farringdon Capital Ltd. acquired a new position in Henry Schein, Inc. (NASDAQ:HSIC - Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm acquired 6,113 shares of the company's stock, valued at approximately $423,000.

A number of other hedge funds have also recently modified their holdings of HSIC. Smartleaf Asset Management LLC increased its position in Henry Schein by 23.2% in the fourth quarter. Smartleaf Asset Management LLC now owns 759 shares of the company's stock worth $52,000 after buying an additional 143 shares in the last quarter. Guggenheim Capital LLC grew its holdings in Henry Schein by 2.5% during the 4th quarter. Guggenheim Capital LLC now owns 6,428 shares of the company's stock valued at $445,000 after buying an additional 159 shares in the last quarter. CIBC Asset Management Inc raised its position in shares of Henry Schein by 1.0% during the fourth quarter. CIBC Asset Management Inc now owns 17,849 shares of the company's stock valued at $1,235,000 after buying an additional 169 shares during the last quarter. Metis Global Partners LLC lifted its holdings in shares of Henry Schein by 4.7% in the fourth quarter. Metis Global Partners LLC now owns 4,203 shares of the company's stock worth $291,000 after buying an additional 187 shares in the last quarter. Finally, Central Pacific Bank Trust Division boosted its holdings in shares of Henry Schein by 2.0% during the 4th quarter. Central Pacific Bank Trust Division now owns 10,200 shares of the company's stock valued at $706,000 after purchasing an additional 200 shares during the last quarter. Institutional investors own 96.62% of the company's stock.

Analyst Ratings Changes

A number of equities analysts recently commented on HSIC shares. Barrington Research reissued an "outperform" rating and set a $90.00 price target on shares of Henry Schein in a research note on Wednesday, February 26th. UBS Group reduced their target price on shares of Henry Schein from $83.00 to $80.00 and set a "neutral" rating on the stock in a report on Wednesday, February 26th. Bank of America raised shares of Henry Schein from an "underperform" rating to a "buy" rating and increased their price target for the company from $69.00 to $84.00 in a report on Monday, January 6th. Jefferies Financial Group raised their price objective on Henry Schein from $77.00 to $80.00 and gave the company a "hold" rating in a research note on Thursday, January 23rd. Finally, StockNews.com lowered Henry Schein from a "buy" rating to a "hold" rating in a report on Thursday, April 17th. Six investment analysts have rated the stock with a hold rating, five have issued a buy rating and one has given a strong buy rating to the company's stock. According to MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus target price of $81.10.

Insider Buying and Selling

In related news, Director Philip A. Laskawy sold 2,604 shares of the business's stock in a transaction on Wednesday, March 19th. The shares were sold at an average price of $71.04, for a total transaction of $184,988.16. Following the completion of the transaction, the director now directly owns 24,805 shares in the company, valued at $1,762,147.20. The trade was a 9.50 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CEO Bradford C. Connett sold 4,036 shares of the stock in a transaction dated Wednesday, March 19th. The stock was sold at an average price of $71.15, for a total value of $287,161.40. Following the sale, the chief executive officer now directly owns 62,688 shares in the company, valued at $4,460,251.20. This represents a 6.05 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.14% of the stock is owned by company insiders.

Henry Schein Stock Up 0.9 %

NASDAQ HSIC traded up $0.58 during trading on Wednesday, reaching $65.12. 242,294 shares of the company's stock traded hands, compared to its average volume of 1,608,381. The firm has a market cap of $7.98 billion, a price-to-earnings ratio of 26.80, a price-to-earnings-growth ratio of 2.13 and a beta of 0.84. Henry Schein, Inc. has a 12-month low of $60.56 and a 12-month high of $82.49. The company has a debt-to-equity ratio of 0.46, a current ratio of 1.42 and a quick ratio of 0.82. The company's 50 day simple moving average is $69.87 and its two-hundred day simple moving average is $71.88.

Henry Schein (NASDAQ:HSIC - Get Free Report) last released its quarterly earnings results on Tuesday, February 25th. The company reported $1.19 earnings per share for the quarter, missing analysts' consensus estimates of $1.23 by ($0.04). Henry Schein had a net margin of 2.51% and a return on equity of 12.90%. The firm had revenue of $3.19 billion during the quarter, compared to the consensus estimate of $3.25 billion. During the same quarter in the prior year, the business posted $0.66 earnings per share. The firm's quarterly revenue was up 5.8% on a year-over-year basis. As a group, sell-side analysts forecast that Henry Schein, Inc. will post 4.74 EPS for the current fiscal year.

Henry Schein Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.